Previous Article | Next Article 
Molecular and Cellular Biology, October 2001, p. 6515-6528, Vol. 21, No. 19
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.19.6515-6528.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Transcriptional Coregulation by the Cell Integrity
Mitogen-Activated Protein Kinase Slt2 and the Cell Cycle
Regulator Swi4
Kristin
Baetz,
Jason
Moffat,
Jennifer
Haynes,
Michael
Chang, and
Brenda
Andrews*
Department of Medical Genetics and
Microbiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Received 19 April 2001/Returned for modification 22 May
2001/Accepted 26 June 2001
 |
ABSTRACT |
In Saccharomyces cerevisiae, the heterodimeric
transcription factor SBF (for SCB binding factor) is composed of Swi4
and Swi6 and activates gene expression at the G1/S-phase
transition of the mitotic cell cycle. Cell cycle commitment is
associated not only with major alterations in gene expression but also
with highly polarized cell growth; the mitogen-activated protein kinase
(MAPK) Slt2 is required to maintain cell wall integrity during periods of polarized growth and cell wall stress. We describe experiments aimed
at defining the regulatory pathway involving the cell cycle transcription factor SBF and Slt2-MAPK. Gene expression assays and
chromatin immunoprecipitation experiments revealed Slt2-dependent recruitment of SBF to the promoters of the G1 cyclins
PCL1 and PCL2 after activation of the
Slt2-MAPK pathway. We performed DNA microarray analysis and identified
other genes whose expression was reduced in both SLT2
and SWI4 deletion strains. Genes that are sensitive to
both Slt2 and Swi4 appear to be uniquely regulated and reveal a role
for Swi4, the DNA-binding component of SBF, which is independent of the
regulatory subunit Swi6. Some of the Swi4- and Slt2-dependent genes do
not require Swi6 for either their expression or for Swi4 localization
to their promoters. Consistent with these results, we found a direct
interaction between Swi4 and Slt2. Our results establish a new
Slt2-dependent mode of Swi4 regulation and suggest roles for Swi4
beyond its prominent role in controlling cell cycle transcription.
 |
INTRODUCTION |
In the budding yeast,
Saccharomyces cerevisiae, the transcription factor SBF (SCB
binding factor) induces cell-cycle-dependent expression of a large
group of genes at the G1/S-phase transition or
Start (reviewed in reference 8). SBF is a heterodimeric complex composed of two proteins, Swi4 and Swi6, which bind the repeated upstream regulatory sequence CACGAAA (SCB, for
Swi4,6-dependent cell cycle box [8, 32]). Biochemical
studies show that Swi4 is the component of SBF that specifically binds
the SCB sequence through an N-terminal helix-turn-helix DNA-binding
domain (55). In contrast, Swi6 has no DNA binding activity
but is present in SBF because of its interaction with Swi4 via the
carboxy-terminal regions of the two proteins (3, 48). Swi6
is also a component of the transcription complex MBF (MCB-binding
factor) that is composed of Swi6 and the DNA binding protein Mbp1 and
binds the promoter element ACGCGT (MCB, for MluI cell cycle
box [8]).
DNA microarray experiments provide an overview of cell-cycle-regulated
genes in budding yeast; more than 200 genes show peak expression in
late G1 phase (G1 genes
[12, 52]). Most of the G1 genes
have at least one SCB or MCB element in their upstream sequences,
implicating SBF and MBF in the induction of many
G1 genes. The G1 group of
genes includes the Cdc28-associated G1 cyclins
CLN1 and CLN2 and the Pho85-associated
G1 cyclins PCL1 and PCL2.
These four cyclins activate their cognate cyclin-dependent kinase (Cdk)
in late G1 and are required for
G1-to-S phase progression (reviewed in reference
2). SBF is essential for the expression of the
G1-specific HO gene and is required
for maximal G1-specific induction of CLN1,
CLN2, PCL1, PCL2, and various cell wall genes (8, 28,
46). Recently, about 200 additional putative targets of SBF and
MBF were identified using yeast intergenic arrays coupled with
chromatin immunoprecipitation (ChIP) (29).
SBF-mediated gene expression is controlled at multiple levels,
including binding of SBF to SCBs, changes in the subcellular localization of Swi6, and the activation of SBF at Start. In vivo footprinting and ChIP experiments show that SBF is bound to the SCBs
upstream of three different SBF-dependent genes throughout late M and
G1 phases (13, 23, 33). SBF binding
to the SCBs of the HO promoter depends on chromatin
remodeling events (13, 34), suggesting that chromatin
remodeling may be a feature of SBF binding to the upstream regulatory
regions of a variety of genes. The binding of SCBs by SBF is not
coincident with SBF-mediated transcription; rather, a second event must
occur for SBF activation, and the Cln3-Cdc28 Cdk plays an important
role in this process (19, 54). In fact, DNA microarray
experiments show that expression of most G1 genes
is induced by overexpression of CLN3 (52). However, the mechanism of Cln3-dependent activation of SBF remains unclear, and direct interaction of Cln3 with SBF has not been reported.
Strains lacking SBF arrest in G1, and many
G1 genes have at least one copy of the SCB
element in their promoters; therefore, a key role of SBF is to promote
G1-specific transcription. However, there are
fewer than 300 genes whose transcription peaks at Start but more than
1,155 genes whose promoters contain matches to the SCB consensus
sequence (http://cgsigma.cshl.org/jian/). A comparison of
the number of SCB sites upstream of G1 genes with
the frequency of SCB sites upstream of a control group of
non-cell-cycle-regulated genes, reveals that SCBs are found more
frequently upstream of non-cell-cycle-regulated genes than MCB sites or
sites for a G2-specific transcription factor
(MCM/SFF sites [52]). This analysis suggests that SCB
elements and SBF may regulate the transcription of many genes other
than those induced at Start.
One pathway that may regulate SBF outside of Start is the protein
kinase C (PKC1) pathway (reviewed in reference
25). PKC1 encodes an essential
serine-threonine-specific protein kinase that is the yeast homolog of
members of the mammalian PKC family of genes (37). Pkc1
activates a mitogen-activated protein kinase (MAPK) cascade that
consists of (i) the MEKK (MAPK kinase kinase) Bck1, (ii) the redundant
MEKs (MAPK kinases) Mkk1 and Mkk2, and (iii) the MAPK Slt2/Mpk1.
pkc1 mutants have thin cell walls and an osmoremedial
sensitivity to a variety of cell wall stresses such as heat shock.
Strains carrying a deletion of BCK1, SLT2, or
both MKK1 and MKK2 are sensitive to high
temperature but are viable at 25°C (35). Since
PKC1 mutants are inviable, PKC1 must have other
roles besides activation of the Slt2-MAPK pathway. Consistent with
these genetic results, recent studies show that PKC1 is
required for both the depolarization and the repolarization of the
actin cytoskeleton upon cell wall stress (18). However, components of the PKC1-MAPK pathway module are required only
for repolarization; both slt2 and bck1 mutants
have a depolarized actin cytoskeleton, with delocalization of actin
cortical spots, abnormal accumulation of secretory vesicles, and
defects in polarized cell growth (14, 18, 43). These
studies suggest that the PKC1-MAPK pathway is required for
cell polarization and for maintenance of cell wall integrity, while an
as-yet-uncharacterized PKC1-dependent pathway is required
for depolarization of the actin cytoskeleton. Slt2 kinase is activated
by heat shock (31) and hypo-osmotic shock
(17) during periods of polarized growth, such as bud
formation and mating projection formation (59), and in
response to actin perturbation (24).
In many systems, the major targets of MAPK cascades are transcription
factors, and activation of the cascade leads to altered gene expression
(reviewed in reference 56). Indeed, recent DNA microarray
work showed transcriptional modulation of 90 genes in a strain
expressing an activated allele of PKC1 (27,
47). Currently, only two transcription factors have been
identified as targets of Slt2: the MADS-box transcription factor Rlm1
(20, 58) and SBF (39). A genome-wide survey
for genes whose expression was altered after expression of a
constitutively active MKK1S386P allele for
4 h identified 25 affected genes (30). Twenty-four of
the MKK1S386P-induced genes were partially
dependent on RLM1. This pattern suggests that, after 4 h of Slt2 activation, Rlm1 may mediate the majority of the Slt2
effects. However, the phenotypes of rlm1
strains are much
less severe than those seen in PKC1-MAPK pathway mutants
(57), suggesting that Rlm1 is not the only important transcriptional target of Slt2. In contrast, swi4 and
swi6 mutant strains share phenotypes similar to those of
strains mutated for PKC1 pathway genes. Some
swi4
strains show a temperature-sensitive growth defect
that is suppressed by sorbitol (28, 39), and both
swi4
and swi6
strains are sensitive to cell
wall stressors (28). Further, like PKC1-MAPK
pathway mutants, swi4 mutants also exhibit defects in both
bud emergence and projection formation (22, 39). These
phenotypic similarities suggested that SBF might be a major
transcriptional target of Slt2. Indeed, genetic studies,
coimmunoprecipitation experiments, and kinase assays have established
SBF as a target of Slt2 kinase (39).
Although the role of Slt2 in SBF regulation is not known, several
observations suggest that Slt2 may activate SBF toward a subset of
target genes. First, genetic evidence suggests a role for the
PKC1-MAPK pathway at Start (41, 43), and this
role may be discharged through SBF. Second, the Pkc1 pathway and Slt2 are required for maximal heat shock-dependent induction of only a
subset of SBF-dependent G1 genes, including
PCL1 and PCL2 (39), and cell wall
genes (28). Finally, overexpression of the
G1 cyclins PCL1 and PCL2,
but not CLN1 or CLN2, suppresses the cell lysis
defects of a slt2
strain (39).
In this study, we test the hypothesis that Slt2 may act to modulate SBF
to induce transcription of only a subset of SBF-dependent genes. We
began by exploring the regulation of the SBF- and Slt2-dependent gene,
PCL1. Our genetic approaches, coupled with DNA microarray analysis and ChIP experiments, establish a new Slt2-dependent mode of
Swi4 regulation and suggest roles for Swi4 beyond cell cycle control.
 |
MATERIALS AND METHODS |
Plasmid constructs
The
PCL1 promoter-lacZ reporter plasmid,
prPCL1
751-146 (pBA537), was previously described as
p
SS-HCS26 (46). To construct a PCL2
promoter-lacZ reporter construct, the
PCL2 promoter from
982 to
82 bp from the start site
was amplified by using primers with the following sequences:
5'-AACGCGTCGACCGTAATTCTATCGATGGACC-3' and
5'-AACGCGTCGACGGAGAATTATAAAGTG-3'. The PCR product was
digested with SalI and cloned into
SalI-digested p
SSBglII to create
plasmid prPCL2
982-82 (pBA1306).
To generate a vector expressing an N-terminal fusion of glutathione
S-transferase (GST) to full-length Slt2, the SLT2
gene was PCR amplified from the previously described plasmid
pFL44-SLT2-HA (BA1019) (59) by using the primers
5'SLT2BamHI(5'-CGTGGATCCTGTAGTGAAAAATTCGAATTT-3') and 3'SLT2EcoR1
(5'-CTCCTAATTCCGTCCTAAAAATATTTTCTATC-3'). The PCR product
was digested with BamHI and EcoRI and cloned into the BamHI/EcoRI sites of the vector pGEX-4T-2
(Pharmacia) to create pBA1382. The integrity of all PCR products was
confirmed by sequence analysis.
Strains and medium.
Yeast strains used in this study are
listed in Table 1. Standard methods and
media were used for yeast growth and transformation. Most of the yeast
strains used in this study are isogenic derivatives of BY263 (an S288C
derivative [45]). Disruption and epitope tagging of SLT2
was achieved by homologous recombination at its chromosomal locus using
a PCR-based method (38). The slt2
strain was
verified by PCR and phenotypic assays. The GFP(S65T)-SLT2
allele was verified by PCR and the functionality of the Slt2 fusion
protein was confirmed by Western blotting, kinase assays, and
complementation of slt2
phenotypes.
-Galactosidase assays.
To assay the activity of
CYC::lacZ reporter genes in log-phase
cultures, yeast transformants were grown in 5 ml of SD-URA medium to an
optical density at 600 nm (OD600) of 0.6 at
30°C. For heat shock experiments, cultures were grown to an
OD600 of 0.6 at 30°C and then transferred to
test tubes that had been preincubated at 39°C, and cultures were
incubated at 39°C for 30 min. To arrest cells with
-factor, cells
were grown in minimal medium supplemented with 1 M sorbitol. Once the
cultures reached an OD600 of 0.3,
-factor
(Procyon Biopharma) was added to the cultures to a final concentration
of 5 µM for 2 h before harvesting. The cells were harvested by
centrifugation at 3,000 × g for 5 min, the cell
pellets were quickly frozen in liquid nitrogen, and the pellets were
stored at
80°C. Liquid
-galactosidase assays were performed on
the frozen pellets as described previously (44). Data are
presented as the mean values from triplicate experiments.
Cell cycle synchronization, heat shock, and ChIP.
For heat
shock experiments, 50-ml cultures of cells were grown to an
OD600 of 0.6. One culture was held at 30°C,
while two other cultures were shifted to 39°C for either 30 or 60 min. Samples of cells were cross-linked with 1% formaldehyde for 15 min with shaking at either 30°C or 39°C. For cell cycle or
-factor treatment experiments, 500-ml cultures were grown at 30°C
to an OD600 of 0.3, and
-factor (Procyon
Bio-Pharma) was added directly to the medium to a final
concentration of 5 µM. Cultures were incubated with
-factor for
2 h until at least 95% of the cells were arrested in
G1 phase as determined by microscopy. Cells were
pelleted and then resuspended in fresh yeast extract-peptone-dextrose
(YPD) medium. Samples (50 ml) were taken before the arrest, before the release, and every 10 min after release and then cross-linked with 1%
formaldehyde for 15 min at 30°C. In both cases, cross-linking was
quenched by the addition of glycine to 125 mM. Cells were pelleted at
3,000 × g for 5 min and washed twice with ice-cold TBS
(150 mM NaCl, 20 mM Tris-HCl; pH 7.6), and whole-cell extracts were
prepared for use in ChIPs basically as described previously (53). Cell lysis was performed in 400 µl of lysis buffer
(50 mM HEPES-KOH [pH 7.5], 140 mM NaCl, 1% Triton X-100, 0.1%
sodium deoxycholate, and one EDTA-Free Protease Inhibitor Pellet
[Boehringer Mannheim] for every 50 ml) and 400 µl of glass beads.
The suspension was sonicated four times for 10 s each time
(resulting in an average fragment size of 0.5 kb) and clarified by
centrifugation for 15 min at 14,000 × g. Protein
concentration for each sample was determined by Bradford assay
(Bio-Rad). Immunoprecipitations were performed with 1 mg of extract at
4°C overnight with rotation on a nutator and either 15 µl of
protein A-Sepharose (pA) alone or 15 µl of pA plus 10 µl of
affinity-purified Swi4 polyclonal antibody or 15 µl of pA plus 5 µl
of affinity-purified Swi6 polyclonal antibody. Precipitates were washed
twice for 10 min each time in 1 ml of lysis buffer and twice for 10 min
each time in 1 ml of TBS. Finally, the samples were processed for DNA
purification as described previously (53).
PCR analysis of immunoprecipitated DNA.
PCRs were carried
out in 25-µl volumes. Serial dilutions of the immunoprecipitated
material and the input material for the whole-cell extracts (WCEs) were
performed to ensure the PCRs were performed in the linear range.
Typically, PCRs were performed with 1/2,000 of the immunoprecipitated
material and 1/20,000 of the input material for WCEs. PCR was performed
using Platinum Taq polymerase (Gibco-BRL) with 25 pmol of
each primer and 0.5 µCi of [
-32P]dATP. For
multiplex PCR with the PCL2, PCL1,
PHO5, and CLN1 promoter primer pairs, 4.0 mM
MgCl2 was used; for PCR with only one primer
pair, 1.5 mM MgCl2 was used. The promoters were
amplified using a cycling program of an initial 2 min of denaturation
at 95°C; followed by 25 cycles of 30 s at 95°C, 30 s at
53°C, and 60 s at 70°C; and a final extension step of 5 min at
70°C. The gene-specific primers were designed as 20-mers with a
roughly 50% GC content. The PCR primer sequences used for the
amplification of promoter regions in PHO5, PCL1,
PCL2, CLN1, RLM1, YLR110c, CWP1, SRL1/YOR248c, and
GIC1 are available upon request. The PCR products were
separated on a 5% polyacrylamide gel, dried, and exposed to Kodak
Biomax-MR film.
Fluorescence microscopy.
Localization of Slt2-GFP(S65T) and
DNA DAPI (4',6'-diamidino-2-phenylindole) staining of live yeast cells
was performed using cultures of BY263 and BY1343 grown to early log
phase in YPD. Cultures were then treated with 5 µM
-factor
for 2 h and washed with a buffer containing 0.1 µg of DAPI/ml.
Cells were observed at a magnification of ×100 using Nomarski optics
or fluorescence through a fluorescein isothiocyanate (FITC) filter to
observe GFP(S65T). Photographs were taken with a Micromax 1300y
high-speed digital camera (Princeton Instruments, Trenton, N.J.)
mounted on a Leica DM-LB microscope. Images from the camera were
analyzed with Metaview software (Universal Imaging, Media, Pa.).
DNA microarray analysis.
Yeast strains were grown in rich
medium at 25°C to an A600 of 0.3 to
0.6. For heat shock experiments, cells were grown to an
A600 of 0.3 at 25°C and then shifted
to 39°C for 45 min. Cells were harvested by centrifugation and then
quickly frozen in liquid nitrogen. Poly(A)+ mRNA
was isolated as described previously (42). Alternatively, total RNA was isolated by hot phenol extraction as described previously (4) with minor modifications. Total RNA was precipitated
from the final aqueous layer and run over a Qiagen RNeasy column to remove smaller RNAs. The final eluate was used as the source of mRNA
for fluorescently labeled cDNA. In order to generate labeled cDNA, ca. 2 to 3 µg of mRNA or 50 µg of total RNA was incubated with Superscript II reverse transcriptase (Gibco-BRL) and Cy3- or
Cy5-dCTP (Mandel) at 42°C for 2 h as described elsewhere
(http://www.oci.utoronto.ca/microarrays).
DNA microarrays consisting of ~97% of the known or predicted genes
of
Saccharomyces cerevisiae were prehybridized with a 1:1:20
solution of tRNA (10 mg/ml)-single-stranded DNA (10 mg/ml)-DIG
Easy
Hyb solution (Roche). The prehybridization mix was heated
to 65°C for
5 min, cooled to 37°C, and applied to the DNA microarray.
The
microarray was covered with a glass coverslip and incubated
at 37°C
for ca. 1 h. Prior to hybridization, DNA microarrays were
washed
in 0.1× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate), and
dried by centrifugation. Labeled cDNAs were applied
to the microarrays
and allowed to hybridize for 12 h at 37°C.
Microarrays were
subjected to three 15-min washes with 0.1× SSC-0.1%
sodium dodecyl
sulfate (SDS) at 45°C, rinsed quickly in 0.1× SSC,
and scanned with
a GSI Lumonics scanner (Watertown, Mass.). Clustering
analysis was
carried out using the Cluster program found at
(
http://rana.stanford.edu/clustering [
21]). Microarray
data represent the averages of three independent
experiments with the
wild-type strain (wt/wt at 25°C) and two
independent experiments with
the
slt2
strain (
slt2
/wt at 25°C),
the
swi4
strain (
swi4
/wt at 25°C), and the
bck1
strain (
bck1
/wt
at 25°C). The
following experiments were also performed in duplicate:
wt/wt, 39°C;
slt2
/wt, 39°C;
swi4
/wt, 39°C; and
slt2/slt2, 25°C
versus 39°C (data not shown; see
Results). Microarray data are
available in full on the Andrews lab
website (
http://lambda.med.utoronto.ca).
Batch affinity chromatography.
GST and GST-Slt2 were
purified from Escherichia coli harboring appropriate
expression plasmids as previously described (45). GST and
GST-Slt2 were bound to glutathione-Sepharose 4B beads (Pharmacia) at
concentrations of 1 and 3 µg/µl of beads, respectively. For
affinity chromatography with in vitro-transcribed and translated Swi4
and Swi6, 20 µl of GST or GST-Slt2 beads was incubated with 18 µl
of lysis buffer (100 mM Tris-HCl [pH 8.0], 1 mM EDTA, 10 mM
MgCl2, 100 mM NaCl, 10% glycerol, 1 mM
dithiothreitol, 0.5% Triton X-100; two EDTA-Free Protease Inhibitor
cocktail tablets [Boehringer Mannheim] per 50 ml) and 2 µl of
either in vitro-translated Swi4 or Swi6 (5) for 2.5 h
at 4°C. The beads were harvested by centrifugation at 2,000 rpm
in an Eppendorf centrifuge for 2 min, and the unbound
supernatant was collected. The beads were washed three times each in
100 µl of lysis buffer. After the final wash, the beads were
resuspended in 20 µl of 1× SDS gel sample buffer and boiled. The
bound and unbound supernatant fractions were separated by SDS-6%
polyacrylamide gel electrophoresis (PAGE). The gels were fixed, treated
with Amplify (Amersham), dried, and exposed to X-ray film.
For affinity chromatography with insect cell-derived SBF, 20 µl of
either GST or GST-Slt2 beads were incubated with 10 µl
of lysis
buffer and 5 µg of partially purified SBF (0.5 µg/µl)
(
5) for 2.5 h at 4°C. The beads were harvested by
centrifugation
at 2,000 ×
g for 2 min, and the unbound
supernatant was collected.
The beads were washed three times each in
100 µl of lysis buffer.
After the final wash, the beads were
resuspended in 20 µl of 1×
SDS sample buffer and boiled. The bound
and unbound supernatant
fractions were separated by SDS-6% PAGE. The
proteins were transferred
to nitrocellulose, and Swi4 and Swi6 proteins
were detected by
Western blotting with either anti-Swi4 or anti-Swi6
antibodies
and detected using enhanced chemiluminescence as described
previously
(
5).
Northern blot analysis.
Yeast strains were grown at 30°C
in YPD medium to an OD600 of 0.4. For
-factor
treatment, cells were treated with 5 µM
-factor (Procyon
BioPharma) for 2 h. Cells were pelleted at 3,000 × g in a 4°C centrifuge for 3 min, and RNA was isolated and
Northern blotting was done as described previously (45).
The probes used for the Northern blot analysis were a 600-bp
EcoRI-HindIII fragment of the ACT1
gene (44), PCR products containing the coding sequence of
PCL1 (45), YLR110c, SRL1, and
GIC1. Sequences of PCR primers are available upon request.
Probes were labeled using random-primed synthesis with Klenow DNA
polymerase in the presence of [
-32P]dATP.
For RNA quantitation, Northern blots were exposed on a Molecular
Dynamics screen and scanned with a Molecular Dynamics PhosphorImager
and analyzed with ImageQuant software (version 3.3).
 |
RESULTS |
Heat shock induction of PCL1 requires Slt2 and Swi4 but not
Swi6.
Upon heat shock, Slt2 is required for a two- to threefold
increase in transcript levels for numerous cell-cycle-regulated genes,
including the G1 cyclins PCL1 and
PCL2 (28, 39). To characterize the molecular
mechanism of the Slt2-dependent transcriptional response, we turned to
an in vivo assay to analyze the roles of Swi6 and Swi4 in the
Slt2-dependent transcription of PCL1. A PCL1 reporter gene was constructed, and sequences spanning from
751 to
146 relative to the PCL1 ATG were placed upstream of a
CYC::lacZ reporter gene on a yeast
vector to create the reporter plasmid prPCL1
751-146 (Fig.
1). To assay the contribution of SBF and
Slt2 to the upstream activating sequence (UAS) activity of the
prPCL1
751-146 reporter, we transformed the wild
type and swi4, swi6, mbp1, and
slt2 mutant strains with the
prPCL1
751-146 plasmid and the control plasmid
CYC1::lacZ and then measured
-galactosidase activity. None of the transformants containing the
control reporter gene produced
-galactosidase activity (data
not shown), while a wild-type strain containing the
prPCL1
751-146 reporter gene had significant
-galactosidase activity at 30°C (Fig. 1). Upon heat shock, the
-galactosidase activity was induced twofold (Fig. 1). Thus, the
behavior of the PCL1 reporter gene in response to heat shock
mirrors that of the endogenous PCL1 gene (39). As previously shown, expression of the
prPCL1
751-146 reporter gene was completely
dependent on Swi4 (Fig. 1 [46]), under normal growth conditions; heat
shock-dependent induction of the PCL1 reporter was also
largely dependent on Swi4 (Fig. 1). Surprisingly, we discovered that
the upstream activation sequence (UAS) activity from the
promoter of prPCL1
751-146 was independent of
Swi6 (Fig. 1). Even though there is one consensus MCB element in the PCL1 promoter, deletion of MPB1 did not affect
prPCL1
751-146 reporter activity. Furthermore,
heat shock-dependent induction of the PCL1 reporter gene was
completely eliminated in the slt2
strain (Fig. 1), a
finding consistent with previous Northern blot experiments
(39). The Swi4-Slt2-dependent but Swi6-independent regulation of the reporter gene was also seen using an upstream segment
of the PCL1 promoter lacking all consensus SCB and MCB elements but containing degenerate matches to the SCB sequence (
751
to
363; data not shown). In addition to the reporter gene assays,
Northern blot analysis was also performed to assay PCL1 transcript levels in log phase cultures of wild-type,
swi4
, and swi6
strains (see Fig. 6). These
blots confirmed that expression of PCL1 was dependent on
Swi4 but independent of Swi6.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 1.
Slt2/Swi4-dependent and Swi6-independent activation of a
PCL1-lacZ reporter gene. Schematic diagram of the
PCL1 upstream regulatory region used to create a
CYC::lacZ reporter construct.
Locations of consensus SCB and MCB motifs are indicated.
Wild-type (Wt, BY263), swi4 (BY108),
swi6 (BY107), mbp1 (BY551),
and slt2 (BY1342) strains were transformed with the
prPCL1 751-146 reporter plasmid and grown at 30°C to log
phase (open bars) or grown at 30°C to log phase and then heat shocked
for 30 min at 39°C (filled bars). Cell lysates were made and
-galactosidase activity (Miller units) was determined. Activity
depicted is the mean of three experiments; the error bars show the
standard deviation for the three experiments.
|
|
Localization of Swi4 and Swi6 to the promoters of PCL1 and PCL2
during G1 phase, pheromone-treatment, and heat shock.
PCL1 gene expression peaks in late G1
(52) and the promoter of PCL1 contains multiple
SCB elements (46). Although Swi6 is only required for the
proper cell cycle-dependent expression of a number of SBF target genes,
we were surprised to find that the heat shock-dependent induction of
PCL1 was independent of Swi6 (see above). Studies to date
show that both Swi4 and Swi6 are required for SCB-driven gene
expression; in the absence of Swi6, Swi4 is unable to bind SCBs both in
vitro (5) and in vivo (23, 33).
To directly examine the association of Swi4 and Swi6 with the
PCL1 and
PCL2 promoters, we performed ChIP assays
by using affinity-purified
Swi4 and Swi6 polyclonal antibodies. Cells
were synchronized in
early G
1 with

-factor and
then released into fresh medium to
allow the cells to progress through
a synchronous cell cycle.
Samples were taken at 10-min intervals
following release from

-factor and were analyzed for position in the
cell cycle by propidium
iodide staining and fluorescence-activated
cell-sorting. Cells
begin to traverse the G
1-S
boundary 20 min after release (data
not shown). For each time point,
the cells were fixed with formaldehyde
and chromatin was isolated using
either the Swi4 or Swi6 antibodies.
The abundance of specific DNA
sequences within the immunoprecipitates
was measured by using PCR and
appropriate primer pairs. Each reaction
mixture contained four sets of
primers, which enabled us to simultaneously
measure the relative
abundance of Swi4 and Swi6 at the promoters
of
PCL1, PCL2,
CLN1, and
PHO5. For
PCL1,
PCL2,
and
CLN1, the primer
pairs were designed to straddle any
recognizable SCB or MCB elements.
PHO5 was chosen as a
negative control since there are no detectable
SCB or MCB elements in
its promoter, its transcription is not
cell cycle regulated
(
52), and there have been no reports of
Swi4- or
Swi6-dependent transcription of
PHO5. ChIP using either
affinity-purified Swi4 or Swi6 antibodies did not enrich for
PHO5 promoter DNA above that seen in negative control assays
using
pA alone (Fig.
2A) or in a ChIP
assay using non-crossed-linked
lysates (NX, Fig.
2A). Further, ChIP
with
swi4
or
swi6
strains
and
affinity-purified Swi4 or Swi6 antibodies, respectively, did
not enrich
for
PCL1,
PCL2, or
CLN1 promoter DNA
(data not shown),
while enrichment of these promoter regions was seen
in the ChIPs
from a wild-type strain. Taken together, these assays
suggest
that our ChIPs are specifically enriched for DNA bound by Swi4
and Swi6 in vivo.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
Swi4 and Swi6 localization to the promoters of
PCL1 and PCL2 during the cell cycle and
after -factor and heat shock treatment. (A) Cell cycle ChIP using
affinity-purified Swi4 antibodies (left panel) and Swi6 antibodies
(right panel). A wild-type strain (BY263) was grown to mid- log phase
and then blocked in G1 with -factor. Cells were
inoculated into fresh medium lacking -factor, and samples were taken
every 10 min. Samples taken of the unsynchronized log-phase culture
(log), the G1 arrested cells ( -factor), and the 10-min
time points were cross-linked with formaldehyde. WCEs were made, and
ChIP was done using pA alone or pA plus affinity-purified Swi4 or Swi6
antibodies as indicated. In the top panels multiplex PCR was performed
to amplify the promoter regions of PCL2, PCL1, PHO5, and
CLN1 in each of the ChIP samples, in an
immunoprecipitation with extract which was not cross-linked (NX), and
in WCEs. The graphs depict the results of phosphorimager analysis of
each PCR product. The results are expressed as a percentage of the
product in the WCE. The experiment shown is representative of three
independent experiments with Swi4 antiserum and two with Swi6
antiserum. (B) Heat shock ChIPs. Cultures of a wild-type strain (BY263)
grown at either 30°C (white bars) or 30°C, followed by heat shock
at 39°C for 30 min (gray bars) or 60 min (black bars) were
cross-linked with formaldehyde. Lysates were made, and ChIP was
performed using pA or with affinity-purified Swi4 antibodies ( -Swi4)
or affinity-purified Swi6 antibodies ( -Swi6). PCR was performed to
amplify the promoters of PCL1, PCL2, and
PHO5 in the ChIP samples and in WCE. The bar graphs
depict the results of phosphorimager analysis of each PCR product. The
results are expressed as a percentage of the product in WCE.
|
|
The localization of Swi4 and Swi6 to the
CLN1 promoter
peaked in late G
1, coincident with the normal
cell-cycle-dependent
activation of genes by SBF (Fig.
2A, 20-min time
point). SBF also
interacted with the promoter of
CLN2 at the
same time (data not
shown). Thus, our ChIP assays, using either Swi4 or
Swi6 antibodies,
provide a representative snapshot of what is occurring
in vivo
during the cell cycle. The cell cycle expression of
PCL1 is similar
to that of
CLN1 and
CLN2, and we found that peak localization
of Swi4 to the
PCL1 promoter also occurred at 20 min. Expression
of
PCL2 peaks earlier than that of
PCL1 and
CLN1 and is partially
dependent on Swi5 (
1). We
did not detect a strong Swi4 or Swi6
association with the
PCL2 promoter during the cell cycle in our
ChIP experiments.
We may have failed to capture peak binding of
SBF to the
PCL2 promoter in the time points used in our assay.
Alternatively, SBF binding to the
PCL2 promoter may not be
required
for cell cycle regulation of
PCL2.
Having established a ChIP assay for SBF localization, we next examined
SBF promoter localization under conditions that activate
the Slt2-MAPK
pathway. Upon

-factor treatment, expression of
the
CLN1,
CLN2, and
PCL1 cyclin genes is repressed. In
contrast,
expression of the
PHO85 cyclin
PCL2 is
immediately induced in
response to

-factor treatment and by
overexpression of
STE12,
the transcription factor activated
by the pheromone response pathway
(
44,
47). Our ChIP assay
showed that Swi4 and Swi6 localization
to either the
CLN1
promoter (Fig.
2A) or the
CLN2 promoter (data
not shown)
remained low during

-factor treatment. However, localization
of Swi4
and Swi6 to the
PCL2 promoter dramatically increased (Fig.
2A). Remarkably, even though the
PCL1 gene is not expressed
during

-factor treatment, Swi4 and Swi6 localization to the
PCL1 promoter
also increased upon

-factor treatment.
Therefore, increased association
of SBF to the
PCL1 promoter
during

-factor treatment is not sufficient
for
PCL1
expression. Nonetheless, we conclude that pheromone treatment
promotes
increased association of SBF to the promoters of a subset
of
genes.
We next asked whether heat shock also affected the localization of SBF
to the promoters of
PCL1 and
PCL2. ChIP
experiments
were performed on cross-linked cells that were grown at
30°C or
cells that were grown at 30°C and heat shocked at 39°C
for either
30 or 60 min. We used Phosphor-Imager analysis to
compare the
PCR product of the ChIP to that of the WCE. Heat shock
increased
the localization of both Swi4 and Swi6 to the promoters of
PCL1 and
PCL2 (Fig.
2B) but not to the promoter
of
CLN1 (data not shown).
In summary, under two conditions
that activate the MAPK Slt2,
heat shock and

-factor treatment, SBF
localization to the promoters
of
PCL1 and
PCL2 increases.
-Factor-dependent induction of PCL2 expression is dependent on
Slt2 and SBF.
Since we saw increased localization of SBF to
PCL promoters during pheromone treatment, we next
investigated the role of Slt2 in this process. First, we asked whether
SBF and Slt2 are required for the pheromone-dependent induction of
PCL2 expression. We used both a reporter gene construct
containing sequences 5' to the PCL2 transcriptional start
(Fig. 3A) and Northern blot analysis (Fig. 3B) to assay PCL2 expression. The sequences upstream
of PCL2 contain a consensus binding site or PRE (pheromone
response element) for Ste12 (reviewed in reference 40). As
expected, the
-factor-dependent induction of both the
PCL2 reporter gene and the endogenous PCL2 gene
were fully dependent on Ste12 (Fig. 3A and B). However, induction of
PCL2 during
-factor treatment was also dependent on Swi4
and Swi6 and partially dependent on Slt2 (Fig. 3; also see Discussion).
Our results suggest that there may be an activation event specific to
SBF on the promoter of PCL2 during the pheromone response.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 3.
Slt2 and SBF activity during -factor treatment. (A)
PCL2 reporter gene assay. Above the graph is a schematic
diagram of the PCL2 promoter region used to create the
PCL2-lacZ reporter construct
prPCL2 -989-82. The locations of the consensus SCB, MCB,
and PRE elements are indicated. The graph shows -factor-induced
expression of -galactosidase from the prPCL2 989-82
reporter plasmid. Wild-type (wt BY263), swi4
(BY1321), swi6 (BY891), slt2
(BY1342), and ste12 (BY332) strains were transformed
with prPCL2 989-82. The transformants were grown to
mid-log phase (open bars) or grown to mid-log phase and treated with 5 µM -factor for 2 h (filled bars). Cell lysates were made, and
the -galactosidase activity (Miller units) of each strain was
determined. Activity depicted is the mean of three experiments; the
error bars show the standard deviations for the three experiments. (B)
PCL2 Northern blots. The indicated strains were grown to
log phase or grown to log phase and treated with 5 µM -factor for
2 h. Total RNA was isolated and probed with PCL2,
followed by the loading control ACT1. Indicated across
the bottom is the fold induction of PCL2 expression
after -factor treatment for each strain. Gel shown is representative
of three independent experiments. (C) Subcellular localization of Slt2
after -factor treatment. BY1343 cells
(SLT2::GFP) were grown in rich
medium to early log phase and then treated with 5 µM -factor for
2 h. Cells were then washed once with buffer containing DAPI and
once with water before examination by fluorescence microscopy at a
magnification of ×1,000. Cells were exposed to fluorescent light
through an FITC filter for 400 ms in order to visualize Slt2-GFP.
Wild-type (BY263) cells treated identically showed no fluorescence.
Photographs of the same fields viewed with Nomarski optics (DIC) and
stained with DAPI to visualize cell nuclei are shown.
|
|
Immunolocalization studies have been conducted using a C-terminally
tagged Slt2 expressed from a plasmid vector (
31). In
these
experiments, Slt2-HA was nuclear during growth at 24°C and
present
throughout the cell when cells were grown for extended
periods of time
at 39°C. Our work predicts that Slt2 will also
be nuclear upon

-factor treatment; therefore, we assayed Slt2
localization in live
cells treated with

-factor. To do this,
we fused green fluorescent
protein (GFP) to the C terminus of
Slt2 at its endogenous locus to
generate Slt2-GFP. Genetic tests
and in vitro kinase assays confirmed
that Slt2-GFP was fully functional
(data not shown). Under normal
growth conditions at 30°C, specific
localization of Slt2-GFP was not
detectable, even though Western
blot analysis showed that Slt2-GFP was
expressed (data not shown).
We presume that the Slt2-GFP signal was
either too low or was
too dispersed throughout the cell for detection.
However, upon

-factor treatment for 1 h, cells expressing the
genomically tagged
Slt2-GFP had distinct nuclear staining, as well as
clear staining
at the shmoo tip in some cells (Fig.
3C). We conclude
that, upon

-factor treatment, Slt2 is localized to the nucleus,
where it
may act directly on components of SBF, Swi4 and
Swi6.
Localization of SBF to the promoters of PCL1 and PCL2 upon heat
shock and pheromone treatment is partially dependent on Slt2.
Since we saw increased binding of SBF to the promoters of
PCL1 and PCL2 in two conditions that activate
Slt2, we next tested the localization of SBF to PCL
promoters in a slt2
strain. We used Swi4 and Swi6
polyclonal antibodies to immunoprecipitate chromatin from formaldehyde
cross-linked wild-type and slt2
cells that were either in
log phase, heat shocked at 39°C for 60 min, or treated with
-factor for 2 h. Since both heat shock and
-factor treatment
cause cell lysis in slt2 mutant cells, both the wild-type and slt2
cells were grown in medium containing sorbitol.
The addition of sorbitol did not affect
-factor induction of
PCL2 promoter activity or heat shock induction of
PCL1 promoter activity (data not shown). In cells grown at
30°C, Swi4 and Swi6 associated with the PCL1 and
PCL2 promoters at similar levels in both wild-type and
slt2
cells (Fig. 4, log
columns). Upon heat shock of wild-type cells, the localization of Swi4
and Swi6 to both the PCL1 and PCL2 promoters
increased (Fig. 2B and 4). However, in slt2
cells, the
enhanced localization of Swi4 and Swi6 to the promoters of PCL1 and PCL2 was reproducibly reduced (Fig. 4B).
As described above,
-factor treatment of wild-type cells also
resulted in increased localization of Swi4 and Swi6 to the
PCL1 and PCL2 promoters (Fig. 3 and 4). As for
heat shock, the localization of SBF to the PCL1 and
PCL2 promoters after pheromone treatment was reproducibly reduced but not eliminated in slt2
cells (Fig. 4). We
conclude that Slt2 contributes to the increased localization of SBF to the promoters of PCL1 and PCL2 upon heat shock
and
-factor treatment.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
Slt2 requirement for SBF localization to the promoters
of PCL1 and PCL2. (A) PCR amplification
of ChIPs from wild-type and slt2 strains. Wild-type
(BY263) and slt2 (BY1342) cultures grown at 30°C
(log), heat shocked for 1 h at 39°C (HS), or treated with
-factor for 2 h ( ) were cross-linked with formaldehyde.
Lysates were made, and ChIPs were performed using pA alone, Swi4
antibodies (Swi4-Ip), or Swi6 antibodies (Swi6-Ip). Multiplex PCR was
used to amplify the promoter regions of PCL2,
PCL1, PHO5, and CLN1 from
each of the immunoprecipitated chromatin reactions and the WCE. (B)
PhosphorImager analysis of each PCR product was performed, and the
localization of Swi4 and Swi6 to the promoters of PCL1,
PCL2, PHO5, and CLN1 is
depicted as percent WCE immunoprecipitated (%WCE Iped). Open bars,
wild-type ChIPs; shaded bars, slt2 ChIPs. The data
shown are representative of two separate experiments.
|
|
DNA microarray analysis of swi4
and
slt2
mutants.
Thus far, our experiments have
identified one gene, PCL1, whose expression depends on
SLT2 and SWI4. To determine whether PCL1 is representative of a larger group of genes, we used
DNA microarrays to assay for genes regulated by both SLT2
and SWI4. We analyzed the genome-wide changes in
transcription by using log-phase cultures of slt2
,
swi4
, and bck1
strains grown at 25°C. We
expected that the subtle effects of Slt2 on gene expression in
log-phase cells meant that this analysis would provide an incomplete view of Slt2-Swi4-regulated genes. However, both Slt2 and Swi4 clearly
have roles in the normal mitotic cell cycle, and we expected that
strongly regulated genes may be uncovered (see Materials and Methods).
We also assayed slt2
and swi4
cells at
39°C since transient heat shock causes a G1
delay and activation of Slt2, thus biasing ourselves to a population of
cells in which both Swi4 and Slt2 are essential.
We first attempted to correlate the
swi4
and
slt2
profiles at 39°C and found a poor degree of
correlation (

= 0.04). In
fact,
swi4
profiles at
25 and 39°C showed an extremely low degree
of correlation (

= 0.12), and the same was true for
slt2
profiles
at 25 and
39°C (

= 0.22). We presume this lack of correlation
reflects
both the pleiotropic effects of heat shock and the multifunctional
nature and nonoverlapping functions of Slt2 and Swi4. Since there
was
little overlap between
swi4
or
slt2
profiles after heat
shock, we instead focused on comparing the
transcriptional profile
from the wild-type strains to the patterns of
gene expression
in
slt2
,
swi4
, and
bck1
cells at 25°C. Analysis of the gene
expression
profiles revealed that the
swi4
signature correlated
with
both the
slt2
and the
bck1
signatures
(

= 0.39 and 0.37
at 25°C, respectively), suggesting
coregulation of genes by
SWI4 and the Slt2-MAPK pathway (see
below for more details). As expected,
the
slt2
and
bck1
profiles correlated to a high degree (

=
0.63 for all genes), a finding consistent with published data
showing
that
BCK1 encodes the MEKK for Slt2 (reviewed in reference
25). In our comparison, we did not observe altered
expression
of previously characterized SBF targets, including
PCL1,
PCL2,
CLN1,
CLN2,
HO,
GAS1,
VAN2,
KRE6, and
CSD2, a result consistent
with previous work (
28,
29,
39). This may be due to lack
of cell synchrony, and we presume
that an analysis of cell populations
synchronized in
G
1 would enhance our ability to detect known SBF
targets (
12,
52). However, a focus on
G
1-specific cells would
also preclude us from
identifying potential genes that are regulated
outside
G
1 phase by
SWI4 and
SLT2,
an important goal of our
study.
In order to make more detailed predictions of potential Swi4-Slt2
target genes, we next compared our
swi4
and
slt2
profiles
with previously published DNA microarray
datasets (
27,
47)
relevant to our experiments (see below).
Previous experiments
include profiles of cells harboring activated
alleles of
PKC1 (
PKC1-R398A) and
RHO1
(
RHO-Q68H), as well as
swi4
and
swi6
cells
(
27,
47).
PKC1 and
RHO1 profiles were chosen since both genes
act upstream of
SLT2 and
SWI4 in a signaling cascade sensitive
to
cell integrity defects (
25). Overall, our DNA microarrays
agree well with previous studies of transcriptional effects following
activation of the PKC1-Slt2 MAPK pathway (data not shown; see
http://lambda.med.utoronto.ca).
We separated genes into classes based on their
SWI4/
SWI6 dependence and their behavior in
bck1
and
slt2
cells or cells carrying
activated
PKC1. Of particular interest for this study were
genes
that showed Swi4 and/or Slt2 dependence and Swi6 independence.
We
selected only those genes whose expression profiles changed
significantly in the mutant strains relative to the wild type
(i.e.,
>1.8-fold; see Materials and Methods). We identified several
genes
whose expression appeared dependent on both
SWI4 and
SLT2.
Some of these genes encoded ribosomal protein
components; this
subgroup of ribosomal protein genes is unlikely to be
significant,
since gene-specific error models place these genes with
others
whose levels fluctuate highly between microarray experiments
(
27).
However, follow-up experiments (see below) showed
that our microarray
analysis indeed identified additional targets of
Swi4 and Slt2.
Expression of
YLR110c and
GIC1 in
log-phase cultures appeared
dependent on
SWI4 and
SLT2 but independent of
SWI6 (Fig.
5).
YRL110c is a previously
uncharacterized gene whose expression is not cell
cycle regulated,
although there is one consensus SCB element upstream
of the gene.
GIC1 encodes a CRIB (Cdc42/Rac-interactive binding)
motif-containing protein that associates with the Cdc42 GTPase
to
promote polarized cell growth (
10,
11).
GIC1
transcription
peaks in S phase, and
GIC1 overexpression can
complement the temperature-sensitive
phenotype of certain
swi4ts alleles (M. Donoviel and B. Andrews, unpublished data). We also
identified genes whose expression
was dependent on Swi4 but independent
of both Swi6 and Slt2 (data not
shown and Fig.
5 [see website
mentioned above]). We performed
follow-up studies on one of these
genes,
SRL1, since Swi6
independence is an unusual property for
Swi4-regulated genes (see
below). It is of interest to note that
SLT2 was upregulated
in
swi4
and
swi6
strains, suggesting that
the
SLT2 pathway may be activated in the absence of
SWI4 or
SWI6.
This result suggests that
SWI4 and
SWI6 may play some part in
downregulating the status of the Slt2-MAPK pathway (
36).
In
summary, our DNA microarray analyses identified genes that were
candidates for coregulation by
SLT2 and
SWI4 and
for
SWI6-independent
regulation by
SWI4.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
DNA microarray analysis. Experiments are listed along
the horizontal axis, and genes are listed along the vertical axis.
Three independent DNA microarray datasets were generated
(slt2 -25°C, swi4 -25°C, and
bck1 -25°C) and compared to two related data sets
from previously published data (swi4 and
swi6 [27]). Genes whose expression
levels were reduced >1.8-fold in swi4 and/or
slt2 cells are shown. Three control experiments were
performed with wild-type RNA (wild-type by wild-type comparison) to
validate the cutoff used in the experiments with the mutant strains
(see Materials and Methods). Cell cycle expression data were obtained
from the Stanford Cell Cycle Expression project and Spellman et al.
(52). SCB and MCB elements were found using the SCPD and
SGD databases available on the internet. Numbers below the colored
squares indicate the intensity ratio between the mutant strain versus
the wild-type strain grown under the same conditions and represent the
average values from two independent experiments. A value of 1 indicates
no change; only genes that were verified by Northern blot analysis are
shown.
|
|
Swi6 independence of newly identified Slt2-Swi4-dependent
genes.
Our PCL1 experiments suggested that genes
regulated by Slt2 and Swi4 may also be independent of Swi6. Indeed, our
analysis of DNA microarray data revealed genes whose expression appears dependent on Swi4 but independent of Swi6 (Fig. 5 [27]).
To further explore our microarray results, we performed both Northern blot analysis and Swi4 ChIP on the Swi4- and Slt2-dependent genes (YLR110c and GIC1) and one Swi4-dependent gene
(SRL1) identified in our microarray experiments. Although
PCL1 was not identified in our DNA microarray analysis, we
included it in our analysis.
For Northern blot analysis, we used probes for the selected genes on
RNA isolated from wild-type,
swi4
,
swi6
,
and
slt2
strains cultured at 30°C (Fig.
6A). As expected from our
PCL1 promoter analysis (Fig.
1),
PCL1 expression is dependent on
Swi4
and independent of Swi6. As predicted from our microarrays,
YLR110c and
GIC1 expression was also dependent on
both Slt2 and Swi4.
Interestingly, like
PCL1,
YLR110c and
GIC1 expression was independent
of
Swi6. We conclude that our microarray analysis has identified
additional genes that appear to be bona fide targets of Swi4 and
Slt2.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
Northern blot analysis and Swi4 localization to the
promoters of newly identified Swi4-Slt2-dependent genes. (A) Northern
blot analysis of a subset of proposed Swi4- and/or Slt2-dependent
genes. Wild-type (Wt, BY263), swi4 (BY108),
swi6 (BY107), and slt2 (BY1342)
cells were grown to mid-log phase at 30°C, and total RNA was isolated
and probed with the indicated open reading frame (ORF). A probe for
ACT1 was used as a loading control. Autoradiograms shown
are representative of one of three experiments. PhosphorImager analysis
was performed, and the signal of each ORF was standardized to the
ACT1 loading control (volume ORF/volume
ACT1). The average standardized signal of three
experiments is indicated beneath each lane. The standard deviation for
each triplicate was <10% of the average. (B) Swi4 localization to the
promoters of Swi4-Slt2-dependent genes. Wild-type (Wt, BY263),
swi6 (BY107), and swi4 (BY108)
cultures grown at 30°C (log) were cross-linked with formaldehyde,
WCEs were made, and ChIPs were performed using pA or Swi4 antibodies
(Swi4-IP). Multiplex PCR was performed as indicated for the ChIP
samples and on fivefold serial dilutions of the WCE to amplify the
promoter regions of the genes listed to the left of the panel.
RLM1 and PHO5 were included as negative
controls. CWP1 was identified as a putative SBF target
in a genome-wide ChIP experiment (29) but did not
immunoprecipitate with Swi4 antibodies in our experiment.
|
|
To test whether the new genes that we identified in our DNA microarray
experiments were direct targets of Swi4, we used our
ChIP assay to
determine whether Swi4 localized to their promoters.
Our attempts at
localizing Slt2 to the promoters of either
PCL1 or
PCL2 have been unsuccessful (data not shown). We performed
Swi4 ChIPs on extracts prepared from wild-type,
swi6
, and
swi4
strains cultured at 30°C. Primers were designed to
specifically
amplify the promoter regions of selected Swi4- and/or
Slt2-dependent
genes and to straddle any recognizable SCB elements. As
expected,
Swi4 did not immunoprecipitate the negative control promoter
PHO5 or the promoter of
RLM1 (Fig.
6B), whose
expression is dependent
on the activation of the
PKC1
pathway and independent of Swi4
(
20,
47). However, we did
detect in wild-type cells Swi4 localization
to the promoters of
YLR110c and
PCL1 and the shared promoter of
SRL1 and
YOR248c. We also detected localization
of Swi4 to the
promoter of
GIC1; however, this localization
was significantly
weaker than the others. In
swi6
strains, Swi4 still localized
to the promoters of
YLR110c,
SRL1 and
PCL1, at only a slightly
reduced level (Fig.
6B). Although Swi4 can bind to the promoters
tested in the absence of
Swi6, our experiments with the
PCL1 promoter
suggest that
Swi6 may be present with Swi4 in the wild-type situation.
Interestingly, as summarized in Fig.
5,
YLR110c is not
classified
as a cell-cycle-regulated gene by DNA microarray analysis
(
12,
52), suggesting that regulation of Swi4 by Slt2 may
allow Swi4
to regulate genes whose expression is not restricted to late
G
1.
Swi4 interacts directly with Slt2 in vitro.
Activation of the
PKC1 pathway by a number of stimuli results in
Slt2-dependent phosphorylation of Swi6 (39). These results have led to the suggestion that Slt2 may regulate gene expression through phosphorylation of Swi6 (39). Several results
suggest that phosphorylation of Swi6 by Slt2 may not be of regulatory significance. First, our promoter analysis of PCL1, along
with DNA microarray and Northern blot analysis, suggests that
expression of Swi4-Slt2-dependent genes may be partially or fully
independent of Swi6. Second, our ChIP experiments showed Swi4
localization to the promoters of PCL1, YLR110c,
and SRL1 genes in the absence of Swi6 (Fig. 6B). Finally, a
phosphorylation site mutant of Swi6, Swi6-SA4 (50), which
cannot be phosphorylated by Slt2 in vivo, does not display any obvious
cell integrity defects (data not shown). As discussed previously, Swi6
independence is an unusual feature of Swi4-dependent genes, and no
other SCB-containing reporter construct has displayed Swi6
independence. Together, these results suggest that Slt2 may not
modulate the activity of Swi6. Instead, Slt2 may regulate Swi4,
possibly through direct interaction of Slt2 with Swi4.
To test whether Slt2 interacts directly with Swi4, we fused
SLT2-HA to GST (
GST-SLT2) and performed batch
affinity chromatography
assays. Slt2-HA was previously used to show
phosphorylation of
Swi4 and Swi6 and also for coimmunoprecipitation
with SBF from
crude yeast extracts (
39). GST or GST-Slt2
was incubated with
full-length Swi4 and Swi6 that was transcribed and
translated
in vitro (Fig.
7B). The
GST-Slt2 fusion bound full-length Swi4
but did not bind full-length
Swi6 (Fig.
7B). This result suggests
that Slt2 can interact directly
with Swi4 but not with Swi6. Previous
coimmunoprecipitation experiments
with crude yeast extracts showed
Swi6 coimmunoprecipitation with Slt2.
To test whether Swi6 coimmunoprecipitation
occurs only in the context
of SBF, we incubated GST or GST-Slt2
with partially purified SBF
produced in insect cells (
5). Both
Swi4 and Swi6 were
detected in the bound fraction when SBF was
incubated with GST-Slt2
(Fig.
7A). Together, our batch affinity
chromatography experiments
demonstrate that Slt2 interacts directly
with Swi4 but not with Swi6.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 7.
Binding of Slt2 to Swi4 and Swi6 in vitro. (A) Five
micrograms of partially purified SBF derived from insect cell extracts
was incubated with either GST or GST-Slt2 immobilized on glutathione
beads. The unbound (U) and bound (B) fractions were separated by
SDS-6% PAGE. The gels were blotted and incubated with Swi4 antiserum
(lanes 1 to 4) or Swi6 antiserum (lanes 5 to 8) to identify Swi4 or
Swi6 proteins. The migration positions of molecular mass markers are
indicated to the left (in kilodaltons). (B) Two microliters of in
vitro-translated Swi4 and Swi6 were incubated with either GST or
GST-Slt2 immobilized on glutathione beads. The unbound (U) and bound
(B) fractions were separately by SDS-6% PAGE. The migration positions
of molecular mass markers are indicated to the left (in kilodaltons).
|
|
 |
DISCUSSION |
We have used genetic and biochemical approaches, along with DNA
microarray analysis, to describe genes whose expression is dependent on
both the cell cycle transcription factor Swi4 and the
PKC1-activated MAPK Slt2. Genes that are sensitive to both Slt2 and Swi4 appear to be uniquely regulated, which may reflect the
ability of Slt2 to modulate the activity of Swi4; in particular, regulation of Swi4 by Slt2 may allow Swi4-dependent transcription in
the absence of Swi6 (summarized in Fig. 8
and discussed further below). Our study also implies roles for Swi4
beyond its prominent role in controlling cell-cycle-dependent
transcription.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
Model for Slt2 and Swi4 coordinate regulation of
PCL1-like genes. Possible modes of regulation of Swi4 by
Slt2 are diagrammed. Swi4 interacts with Swi6 to form SBF (in dashed
box) to control expression of G1-specific transcripts
(HO, CLN1, CLN2,
PCL1, etc.) via binding to SCB elements. In our model,
phosphorylation of Swi4 by Slt2, either on its own or complexed with
Swi6, may relieve the autoinhibition of Swi4 DNA binding. Regulation of
Swi4 by Slt2 may impart a unique Swi6-independent function to Swi4 that
directs activation of a subset of Swi4-Slt2-dependent genes
(PCL1, SRL1, etc.). Genes controlled by
Swi4 and Slt2 include non-cell-cycle-regulated genes and define a novel
role for Swi4 beyond its major role in controlling cell-cycle-dependent
transcription.
|
|
Swi4 and Slt2 coregulate a subset of genes.
In order to
understand the transcriptional role of Swi4 and Slt2 in maintaining
cell wall integrity, we performed DNA microarray analysis to identify
genes that require both Slt2 and Swi4 for their expression. Through
careful analysis of our microarray data and other published datasets,
we identified genes whose expression was reduced in both
SWI4 and SLT2 deletion strains (Fig. 5). Although Northern blot analysis and ChIP experiments generally support the
validity of the microarray data, we are unlikely to have identified all
Slt2-Swi4-dependent genes. First, we performed our microarrays using
RNA probes from log-phase cells in an attempt to minimize cell cycle
effects. Second, many Slt2-dependent transcriptional effects range from
1.2- to 2-fold changes (28, 30, 39), which is below the
cutoff for our microarray analysis (1.8-fold). Indeed, our limits
exclude the possibility of identifying known Slt2-Swi4-dependent genes,
including PCL1 and several cell wall biosynthetic genes
(28).
As expected, we identified SBF-dependent genes in our microarray
analysis, which are cell cycle-regulated in G
1
and S phase,
when SBF-dependent transcription normally occurs (data not
shown;
see website cited above). However, our microarray analysis and
other experiments suggest a new role for Swi4 that may not be
discharged through its well-characterized function in SBF. First,
expression of one Swi4-Slt2-dependent gene,
YRL110c, is not
G
1 specific; however, our ChIP experiments show
that Swi4 is localized
to the promoter of
YLR110c. These
experiments suggest a role for
Swi4 in regulating genes outside of
G
1 phase.
YLR110c and a number
of
other genes were also earmarked as putative SBF targets using
a genomic
ChIP approach (
29). Second, we identified Swi4-dependent
genes in our microarray experiments that were Swi6 independent
(Fig.
5). We think it unlikely that the Swi6 independence reflects
Swi4
misregulation (
49), since dominant transcriptional effects
of Swi4 in
swi6
backgrounds have been reported only for
strains
overexpressing full-length Swi4 or expressing C-terminally
truncated
alleles of Swi4 (
5,
49). Also, we did identify
many genes
with the expected dependence on both Swi4 and Swi6 (data not
shown).
Together with our
PCL1 experiments, our data
strongly suggest
that Swi4 can function independently of Swi6 and
outside of G
1 phase, revealing a new cellular
role for Swi4 (see below for further
discussion).
Role of the PKC1 pathway and SBF in pheromone response.
In
addition to regulating a subset of Swi4 targets during mitotic growth,
our work suggests that Slt2 may also partner with Swi4 to regulate the
pheromone-dependent induction of gene expression. DNA microarrays have
been used to examine genome-wide patterns of gene expression in
response to pheromone treatment (47). Interestingly,
pheromone treatment induces both an early transcriptional response
dependent on Ste12 and a later transcriptional response dependent on
PKC1. The late-induced genes are not enriched for Ste12
binding sites (PREs) in their promoters, nor are they induced by
overexpression of STE12. These results suggest that the
PKC1-MAPK pathway likely activates other transcription
factors necessary for the late pheromone-induced genes.
PCL2 was identified as an early pheromone-induced gene,
whose expression was dependent on
STE12. Our studies confirm
that
induction of
PCL2 expression in response to

-factor
depends on
Ste12 but also reveal a requirement for both Swi4 and Slt2
for
the full activation of
PCL2 (Fig.
3A and B). This
pattern of dependency
suggests that the
PCL2 gene may be
responsive to both early and
late pheromone signals, requiring Ste12
for early pheromone response
and requiring Slt2 and SBF for the late
pheromone response. Alternatively,
there may be a subset of
pheromone-responsive genes whose full
induction is dependent on Ste12,
Slt2, and
SBF.
Unlike
PCL2,
PCL1 expression is not induced by

-factor. Nonetheless, we saw an enrichment of SBF on the promoter of
PCL1 upon

-factor treatment (Fig.
2 and
4). As described
earlier,
SBF localization to G
1-specific
promoters in early G
1 phase is
necessary but not
sufficient for transcription activation. Our
results show that SBF
binding to promoters during the transcriptional
response to pheromone
treatment is also not sufficient for activation
of transcription; in
both cases, it is clear that SBF-dependent
transcription requires an
activation event. Interestingly, Slt2
has some transactivation activity
(
15,
51). Although we have
shown that Slt2-GFP localizes
to the nucleus upon

-factor treatment
(Fig.
3C), our attempts at
localizing Slt2 to the promoters of
either
PCL1 or
PCL2 have been unsuccessful. Either Slt2 does not
localize
to DNA or its interaction with promoters is transient
and not
detectable using ChIP assays. Alternatively, SBF activation
in response
to Slt2 may require other
proteins.
Both our
PCL2 reporter assay and Northern analysis show that
the

-factor induction of
PCL2 is fully dependent on Swi6
but
only partially dependent on Swi4. This is in contrast to the
behavior
of
PCL1, whose log-phase and heat shock expression
is independent
of Swi6 (Fig.
1 and
6). One intriguing possibility is
that Swi6
is required only to mediate a subset of
PKC1-MAPK-mediated responses.
Although both
swi6
and
swi4
strains are sensitive to
variety
of cell walls stressors, only
swi4
strains and
not
swi6
strains
are temperature sensitive for growth at
37°C (
22,
28,
39),
and overexpression of
SWI4
but not of
SWI6 can rescue the temperature
sensitivity of
PKC1-MAPK pathway mutants (
28,
39). Since
overexpression
of
MBP1, the other known DNA-binding partner
of Swi6, does not
rescue
PKC1-MAPK pathway mutants
(
28,
39), cell wall defects
of
swi6 mutants are
likely due to inappropriate regulation of
Swi4-dependent transcription.
However, the possibility that Swi6
regulates other transcription
factors cannot be
excluded.
Slt2-dependent regulation of Swi4.
As mentioned above, both
our PCL1::lacZ reporter gene and
Northern blot analyses show that PCL1 expression is
dependent on Swi4 and partially dependent on Slt2 but independent of
Swi6 (Fig. 1 and 6). Swi6 independence is not unique to the
PCL1 gene. As discussed above, our microarray experiments
identified other genes whose expression during log phase is dependent
on Swi4 but independent of Swi6. Further, our Northern blot analysis
confirmed that the log-phase levels of PCL1 and
YLR110c mRNA are Swi6 independent and that the log phase
levels of GIC1 and SRL1 mRNA are partially independent of Swi6. Surprisingly, Swi4 was also localized to the
promoters of PCL1, SRL1, and YLR110c
in the absence of Swi6. This result contrasts with a previous Swi4 ChIP
study, which showed that Swi6 was required for Swi4 localization to the
SCBs of the promoter of HO endonuclease (13),
whose activity is fully dependent on Swi6 (9). In the same
study, Swi6-independent localization of Swi4 to the promoter of
CLN2 was detected; however, we find that expression of
CLN2 is not affected by deletion of SLT2 (data not shown). Clearly, Swi4 regulation is complex, and we propose that,
in the absence of Swi6, Slt2 may control the binding of Swi4 to only a
subset of Swi4-dependent genes.
Our work suggests that Slt2-Swi4-dependent genes are largely
independent of Swi6. Consistent with this, we demonstrated that
Slt2
interacts directly with Swi4 and not Swi6 (Fig.
7). A model
to explain
the apparent Swi6-independent regulatory properties
of Swi4 is shown in
Fig.
8. Both in vitro and in vivo experiments
show that Swi4 has no
intrinsic ability to bind SCB-containing
DNA in the absence of Swi6 due
to autoinhibition of DNA binding
involving both the DNA-binding domain
of Swi4 and the C-terminal
region that interacts with Swi6
(
5). Phosphorylation of Swi4
by Slt2 may relieve the
intramolecular interactions that prevent
Swi4 from binding DNA in the
absence of Swi6. This regulation
of Swi4 binding activity by Slt2 could
occur in either the presence
or the absence of Swi6. Consistent with
this model, coimmunoprecipitation
experiments and kinase assays show
that Slt2 can interact with
and phosphorylate both Swi6 and Swi4 in
vitro (Fig.
7 and 39).
Phosphorylation regulates DNA binding by the
Ets-1 transcription
factor by modulating its autoinhibitory mechanism
(
16); likewise,
phosphorylation of Swi4 might affect its
autoinhibition of DNA
binding or the sequence specificity of DNA
binding.
Another possibility is that Slt2 may regulate the interaction of Swi4
with another transcription factor, which can alleviate
the
autoinhibition of Swi4 DNA binding and/or alter the DNA-binding
specificity of Swi4. The Swi4 homolog, Mbp1, can interact with
the
transcription factor Skn7 instead of Swi6, and the interaction
of Mbp1
with Skn7 alters the activity and promoter specificity
of Mbp1
(
7). Likewise, Swi4 may also have alternative partners
that regulate the binding of Swi4 to
DNA.
MAPKs have been implicated in the regulation of chromatin
remodeling (
6). Recent studies of the SBF-dependent gene
HO show
that directed chromatin remodeling of the locus is
required before
Swi4 can bind the promoter (
13,
34). The
promoters of other
Swi4-dependent genes may also require chromatin
remodeling to
allow Swi4 DNA binding. One of the roles of Slt2 may be
to activate
or coordinate chromatin remodeling on the promoters of
Slt2-dependent
genes to allow Swi4 to specifically bind only these
promoters
and not all SBF-dependent genes. In agreement with this idea,
our ChIP experiments show that Slt2 is partially responsible for
localizing Swi4 and Swi6 to the promoters of
PCL1 and
PCL2 upon
heat shock and

-factor treatment. Currently,
only three in vivo
targets of Slt2 have been identified; a more
complete view of
in vivo substrates of Slt2 will be required to better
define the
dual role of Slt2 and Swi4 in activating gene
transcription.
 |
ACKNOWLEDGMENTS |
We thank H. Friesen for discussion and comments on the manuscript
and P. Jorgensen, B. J. Breitkrutz, and M. Tyers for help with DNA microarrays.
K.B. was a research student of the National Cancer Institute of Canada
and was supported by funds provided by the Terry Fox Run. J.M. holds a
Doctoral Award from the Canadian Institutes of Health Research (CIHR),
and B.A. is a CIHR Scientist. This work was supported by a grant from
the CIHR.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Genetics and Microbiology, University of Toronto, 1 Kings
College Circle, Toronto, Ontario M5S 1A8, Canada. Phone: (416)
978-8562. Fax: (416) 971-2494. E-mail:
brenda.andrews{at}utoronto.ca.
 |
REFERENCES |
| 1.
|
Aerne, B. L.,
A. L. Johnson,
J. H. Toyn, and L. Johnston.
1998.
Swi5 controls a novel wave of cyclin synthesis in late mitosis.
Mol. Biol. Cell
9:945-956[Abstract/Free Full Text].
|
| 2.
|
Andrews, B., and V. Measday.
1998.
The cyclin family of budding yeast: abundant use of a good idea.
Trends Genet.
14:66-72[CrossRef][Medline].
|
| 3.
|
Andrews, B. J., and L. A. Moore.
1992.
Interaction of the yeast Swi4 and Swi6 cell cycle regulatory protein in vitro.
Proc. Natl. Acad. Sci. USA
89:11852-11856[Abstract/Free Full Text].
|
| 4.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl.
1993.
Current protocols in molecular biology, vol. 2.
John Wiley & Sons, Inc., Boston, Mass.
|
| 5.
|
Baetz, K., and B. Andrews.
1999.
Regulation of the cell cycle transcription factor Swi4 through auto-inhibition of DNA binding.
Mol. Cell. Biol.
19:6729-6741[Abstract/Free Full Text].
|
| 6.
|
Belotserkovskaya, R., and S. L. Berger.
1999.
Interplay between chromatin modifying and remodeling complexes in transcriptional regulation.
Crit. Rev. Eukaryot. Gene Expr.
9:221-230[Medline].
|
| 7.
|
Bouquin, N.,
A. L. Johnson,
B. A. Morgan, and L. H. Johnston.
1999.
Association of the cell cycle transcription factor Mbp1 with the Skn7 response regulator in budding yeast.
Mol. Biol. Cell
10:3389-3400[Abstract/Free Full Text].
|
| 8.
|
Breeden, L.
1996.
Start-specific transcription in yeast.
Curr. Top. Microbiol. Immunol.
208:95-127[Medline].
|
| 9.
|
Breeden, L. L., and K. Nasmyth.
1987.
Cell cycle control of the yeast HO gene: cis- and trans-acting regulators.
Cell
48:389-397[CrossRef][Medline].
|
| 10.
|
Brown, J. L.,
M. Jaquenoud,
M. P. Gulli,
J. Chant, and M. Peter.
1997.
Novel Cdc42-binding proteins Gic1 and Gic2 control cell polarity in yeast.
Genes Dev.
11:2972-2982[Abstract/Free Full Text].
|
| 11.
|
Chen, G. C.,
Y. J. Kim, and C. S. Chan.
1997.
The Cdc42 GTPase-associated proteins Gic1 and Gic2 are required for polarized cell growth in Saccharomyces cerevisiae.
Genes Dev.
11:2958-2971[Abstract/Free Full Text].
|
| 12.
|
Cho, R. J.,
M. J. Campbell,
E. A. Winzeler,
L. Steinmetz,
A. Conway,
L. Wodicka,
T. G. Wolfsberg,
A. E. Gabrielian,
D. Landsman,
D. J. Lockhart, and R. W. Davis.
1998.
A genome-wide transcriptional analysis of the mitotic cell cycle.
Mol. Cell
2:65-73[CrossRef][Medline].
|
| 13.
|
Cosma, M. P.,
T. Tanaka, and K. Nasmyth.
1999.
Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter.
Cell
97:299-311[CrossRef][Medline].
|
| 14.
|
Costigan, C.,
S. Gehrung, and M. Snyder.
1992.
A synthetic lethal screen identifies Slk1, a novel protein kinase homolog implicated in yeast cell morphogenesis and cell growth.
Mol. Cell. Biol.
12:1162-1178[Abstract/Free Full Text].
|
| 15.
|
Costigan, C.,
D. Kolodrubetz, and M. Snyder.
1994.
NHP6A and NHP6B, which encode HMG1-like proteins, are candidates for downstream components of the yeast SLT2 mitogen-activated protein kinase pathway.
Mol. Cell. Biol.
14:2391-2403[Abstract/Free Full Text].
|
| 16.
|
Cowley, D. O., and B. J. Graves.
2000.
Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition.
Genes Dev.
14:366-376[Abstract/Free Full Text].
|
| 17.
|
Davenport, K. R.,
M. Sohaskey,
Y. Kamada,
D. E. Levin, and M. C. Gustin.
1995.
A second osmosensing signal transduction pathway in yeast.
J. Biol. Chem.
270:30157-30161[Abstract/Free Full Text].
|
| 18.
|
Delley, P.-A., and M. N. Hall.
1999.
Cell wall stress depolarizes cell growth via hyperactivation of RHO1.
J. Cell Biol.
147:163-174[Abstract/Free Full Text].
|
| 19.
|
Dirick, L.,
T. Bohm, and K. Nasymth.
1995.
Roles and regulation of Cln/Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae.
EMBO J.
14:4803-4813[Medline].
|
| 20.
|
Dodou, E., and R. Treisman.
1997.
The Saccharomyces cerevisiae MADS-box transcription tactor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway.
Mol. Cell. Biol.
17:1848-1859[Abstract].
|
| 21.
|
Eisen, M. B.,
P. T. Spellman,
P. O. Brown, and D. Botstein.
1998.
Cluster analysis and display of genome-wide expression patterns.
Proc. Natl. Acad. Sci. USA
95:14864-14868.
|
| 22.
|
Gray, J. V.,
J. P. Ogas,
Y. Kamada,
M. Stone,
D. E. Levin, and I. Herskowitz.
1997.
A role for the Pkc1 MAP kinase pathway of Saccharomyces cerevisiae in bud emergence and identification of a putative upstream regulator.
EMBO J.
16:4924-4937[CrossRef][Medline].
|
| 23.
|
Harrington, L. A., and B. J. Andrews.
1996.
Binding to the yeast Swi4,6-dependent cell cycle box, CACGAAA, is cell cycle regulated in vivo.
Nucleic Acids Res.
24:558-565[Abstract/Free Full Text].
|
| 24.
|
Harrison, J. C.,
E. S. G. Bardes,
Y. Ohya, and D. J. Lew.
2001.
A role for the Pkc1p/Mpk1p kinase cascade in the morphogenesis checkpoint.
Nat. Cell Biol.
3:417-420[CrossRef][Medline].
|
| 25.
|
Heinisch, J. J.,
A. Lorberg,
H.-P. Schmitz, and J. J. Jacoby.
1999.
The protein kinase C-mediated MAP kinase pathway involved in the maintenance of cellular integrity in Saccharomyces cerevisiae.
Mol. Microbiol.
32:671-680[CrossRef][Medline].
|
| 26.
|
Ho, Y.,
S. Mason,
R. Kobayashi,
M. Hoekstra, and B. Andrews.
1997.
Role of the casein kinase I isoform, Hrr25, and the cell-cycle-regulatory transcription factor, SBF, in the transcriptional response to DNA damage in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
94:581-586[Abstract/Free Full Text].
|
| 27.
|
Hughes, T.,
M. Marton,
A. Jones,
C. Roberts,
R. Stoughton,
C. Armour,
H. Bennett,
E. Coffey,
H. Dai,
Y. He,
M. Kidd,
A. King,
M. Meyer,
D. Slade,
P. Lum,
S. Stepaniants,
D. Shoemaker,
D. Gachotte,
K. Chakraburtty,
J. Simon,
M. Bard, and S. Friend.
2000.
Functional discovery via a compendium of expression profiles.
Cell
102:109-126[CrossRef][Medline].
|
| 28.
|
Igual, J.,
A. Johnson, and L. Johnston.
1996.
Coordinated regulation of gene expression by the cell cycle transcription factor Swi4 and the protein kinase C MAP kinase pathway for yeast cell integrity.
EMBO J.
15:5001-5013[Medline].
|
| 29.
|
Iyer, V. R.,
C. A. Horak,
C. S. Scafe,
D. Botstein,
M. Snyder, and P. O. Brown.
2001.
Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF.
Nature
409:533-538[CrossRef][Medline].
|
| 30.
|
Jung, U. S., and D. E. Levin.
1999.
Genome-wide analysis of gene expression regulated by the yeast cell wall integrity signalling pathway.
Mol. Microbiol.
34:1049-1057[CrossRef][Medline].
|
| 31.
|
Kamada, Y.,
U. S. Jung,
J. Piotrowski, and D. E. Levin.
1995.
The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response.
Genes Dev.
9:1559-1571[Abstract/Free Full Text].
|
| 32.
|
Koch, C., and K. Nasmyth.
1994.
Cell cycle regulated transcription in yeast.
Curr. Opin. Cell Biol.
6:451-459[CrossRef][Medline].
|
| 33.
|
Koch, C.,
A. Schleiffer,
G. Ammerer, and K. Nasmyth.
1996.
Switching transcription on and off during the yeast cell cycle: Cln/Cdc28 kinases activate bound transcription factor SBF (Swi4/Swi6) at Start, whereas Clb/Cdc28 kinases displace it from the promoter in G2.
Genes Dev.
10:129-141[Abstract/Free Full Text].
|
| 34.
|
Krebs, J. E.,
M.-H. Kuo,
C. D. Allis, and C. L. Peterson.
1999.
Cell cycle-regulated histone acetylation required for expression of the yeast HO gene.
Genes Dev.
13:1412-1421[Abstract/Free Full Text].
|
| 35.
|
Lee, K., and D. E. Levin.
1992.
Dominant mutations in a gene encoding a putative protein kinase (BCK1) bypass the requirement for a Saccharomyces cerevisiae protein kinase C homolog.
Mol. Cell. Biol.
12:172-182[Abstract/Free Full Text].
|
| 36.
|
Lenburg, M. E., and E. K. O'Shea.
2001.
Genetic evidence for a morphogenetic function of the Saccharomyces cerevisiae Pho85 cyclin-dependent kinase.
Genetics
157:39-51[Abstract/Free Full Text].
|
| 37.
|
Levin, D. E.,
F. O. Fields,
R. Kunisawa,
J. M. Bishop, and J. Thorner.
1990.
A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle.
Cell
62:213-224[CrossRef][Medline].
|
| 38.
|
Longtine, M. S.,
A. McKenzie,
D. J. Demarini,
N. G. Shah,
A. Wach,
A. Brachat,
P. Philippsen, and J. R. Pringle.
1998.
Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae.
Yeast
10:953-961.
|
| 39.
|
Madden, K.,
Y.-J. Sheu,
K. Baetz,
B. Andrews, and M. Snyder.
1997.
SBF cell cycle regulator as a target of the yeast PKC-MAP kinase pathway.
Science
275:1781-1784[Abstract/Free Full Text].
|
| 40.
|
Madhani, H. D., and G. R. Fink.
1998.
The riddle of MAP kinse signaling specificity.
Trends Genet.
14:151-155[CrossRef][Medline].
|
| 41.
|
Marini, N. J.,
E. Meldrum,
B. Buehrer,
A. V. Hubberstey,
D. E. Stone,
A. Traynor-Kaplan, and S. I. Reed.
1996.
A pathway in yeast cell division cycle linking protein kinase C (Pkc1) to activation of Cdc28 at START.
EMBO J.
15:3040-3052[Medline].
|
| 42.
|
Marton, M. J.,
J. L. DeRisi,
H. A. Bennett,
V. R. Iyer,
M. R. Meyer,
C. J. Roberts,
R. Stoughton,
J. Burchard,
D. Slade,
H. Dai,
D. E. Bassett,
L. H. Hartwell,
P. O. Brown, and S. H. Friend.
1998.
Drug target validation and identification of secondary drug target effects using DNA microarrays.
Nat. Med.
4:1293-1301[CrossRef][Medline].
|
| 43.
|
Mazzoni, C.,
P. Zarov,
A. Rambourg, and C. Mann.
1993.
The SLT2 (MPK1) MAP kinase homolog is involved in polarized cell growth in Saccharomyces cerevisiae.
J. Cell Biol.
123:1821-1833[Abstract/Free Full Text].
|
| 44.
|
Measday, V.,
L. Moore,
J. Ogas,
M. Tyers, and B. Andrews.
1994.
The PCL2(ORFD)-PHO85 cyclin-dependent kinase complex: a cell cycle regulator in yeast.
Science
266:1391-1395[Abstract/Free Full Text].
|
| 45.
|
Measday, V.,
L. Moore,
R. Retnakaran,
J. Lee,
M. Donoviel,
A. M. Neiman, and B. Andrews.
1997.
A family of cyclin-like proteins that interact with Pho85 cyclin-dependent kinase.
Mol. Cell. Biol.
17:1212-1223[Abstract].
|
| 46.
|
Ogas, J.,
B. J. Andrews, and I. Herskowitz.
1991.
Transcriptional activation of CLN1, CLN2 and a putative new G1 cyclin (HCS26) by Swi4, a positive regulator of G1 specific transcription.
Cell
66:1015-1026[CrossRef][Medline].
|
| 47.
|
Roberts, C. J.,
B. Nelson,
M. J. Marton,
R. Stoughton,
M. R. Meyer,
H. A. Bennett,
Y. D. He,
H. Dai,
W. L. Walker,
T. R. Hughes,
M. Tyers,
C. Boone, and S. H. Friend.
2000.
Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles.
Science
287:873-880[Abstract/Free Full Text].
|
| 48.
|
Sidorova, J. M., and L. L. Breeden.
1993.
Analysis of the SWI4/SWI6 protein complex, which directs G1/S-specific transcription in Saccharomyces cerevisiae.
Mol. Cell. Biol.
13:1069-1077[Abstract/Free Full Text].
|
| 49.
|
Sidorova, J. M., and L. L. Breeden.
1997.
Rad53-dependent phosphorylation of Swi6 and downregulation of CLN1 and CLN2 transciption occur in response to DNA damage in Saccharomyces cerevisiae.
Genes Dev.
11:3032-3045[Abstract/Free Full Text].
|
| 50.
|
Sidorova, J. M.,
G. E. Mikesell, and L. L. Breeden.
1995.
Cell cycle-regulated phosphorylation of Swi6 controls its nuclear localization.
Mol. Biol. Cell
6:1641-1658[Abstract].
|
| 51.
|
Soler, M.,
A. Plovins,
H. Martin,
M. Molina, and C. Nombela.
1995.
Characterization of domains in the yeast MAP kinse Slt2 (Mpk1) required for functional activity and in vivo interaction with protein kinases Mkk1 and Mkk2.
Mol. Microbiol.
17:833-842[CrossRef][Medline].
|
| 52.
|
Spellman, P. T.,
G. Sherlock,
M. Q. Zhang,
V. R. Iyer,
K. Anders,
M. B. Eisen,
P. O. Brown,
D. Botstein, and B. Futcher.
1998.
Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization.
Mol. Biol. Cell
9:3273-3297[Abstract/Free Full Text].
|
| 53.
|
Strahl-Bolsinger, S.,
A. Hecht,
K. Luo, and M. Grunstein.
1997.
SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast.
Genes Dev.
11:83-93[Abstract/Free Full Text].
|
| 54.
|
Stuart, D., and C. Wittenberg.
1995.
CLN3, not positive feedback, determines CLN2 transcription in cycling cells.
Genes Dev.
9:2780-2794[Abstract/Free Full Text].
|
| 55.
|
Taylor, I. A.,
P. B. McIntosh,
P. Pala,
M. K. Treiber,
S. Howell,
A. N. Lane, and S. J. Smerdon.
2000.
Characterization of the DNA-binding domains from the yeast cell-cycle transcription factors Mbp1 and Swi4.
Biochemistry
39:3943-3954[CrossRef][Medline].
|
| 56.
|
Treisman, R.
1996.
Regulation of transcription by MAP kinase cascades.
Curr. Opin. Cell Biol.
8:205-215[CrossRef][Medline].
|
| 57.
|
Watanabe, Y.,
K. Irie, and K. Matsumoto.
1995.
Yeast RLM1 encodes a serum response factor-like protein that may function downstream of the Mpk1 (Slt2) mitogen-activated protein kinase pathway.
Mol. Cell. Biol.
15:5740-5749[Abstract].
|
| 58.
|
Watanabe, Y.,
G. Takaesu,
M. Hagiwara,
K. Irie, and K. Matsumoto.
1997.
Characterization of a serum response factor-like protein in Saccharomyces cerevisiae, Rlm1, which has transcriptional activity regulated by the Mpk1 (Slt2) mitogen-activated protein kinase pathway.
Mol. Cell. Biol.
17:2615-2623[Abstract].
|
| 59.
|
Zarzov, P.,
C. Mazzoni, and C. Mann.
1996.
The SLT2 (MPK1) MAP kinase is activated during periods of polarized cell growth in yeast.
EMBO J.
15:83-91[Medline].
|
Molecular and Cellular Biology, October 2001, p. 6515-6528, Vol. 21, No. 19
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.19.6515-6528.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Truman, A. W., Kim, K.-Y., Levin, D. E.
(2009). Mechanism of Mpk1 Mitogen-Activated Protein Kinase Binding to the Swi4 Transcription Factor and Its Regulation by a Novel Caffeine-Induced Phosphorylation. Mol. Cell. Biol.
29: 6449-6461
[Abstract]
[Full Text]
-
Gomez, A., Perez, J., Reyes, A., Duran, A., Roncero, C.
(2009). Slt2 and Rim101 Contribute Independently to the Correct Assembly of the Chitin Ring at the Budding Yeast Neck in Saccharomyces cerevisiae. Eukaryot Cell
8: 1449-1459
[Abstract]
[Full Text]
-
Birkaya, B., Maddi, A., Joshi, J., Free, S. J., Cullen, P. J.
(2009). Role of the Cell Wall Integrity and Filamentous Growth Mitogen-Activated Protein Kinase Pathways in Cell Wall Remodeling during Filamentous Growth. Eukaryot Cell
8: 1118-1133
[Abstract]
[Full Text]
-
Garcia, R., Rodriguez-Pena, J. M., Bermejo, C., Nombela, C., Arroyo, J.
(2009). The High Osmotic Response and Cell Wall Integrity Pathways Cooperate to Regulate Transcriptional Responses to Zymolyase-induced Cell Wall Stress in Saccharomyces cerevisiae. J. Biol. Chem.
284: 10901-10911
[Abstract]
[Full Text]
-
Krause, S. A., Xu, H., Gray, J. V.
(2008). The Synthetic Genetic Network around PKC1 Identifies Novel Modulators and Components of Protein Kinase C Signaling in Saccharomyces cerevisiae. Eukaryot Cell
7: 1880-1887
[Abstract]
[Full Text]
-
Kim, K.-Y., Truman, A. W., Levin, D. E.
(2008). Yeast Mpk1 Mitogen-Activated Protein Kinase Activates Transcription through Swi4/Swi6 by a Noncatalytic Mechanism That Requires Upstream Signal. Mol. Cell. Biol.
28: 2579-2589
[Abstract]
[Full Text]
-
Mitchell, L., Lambert, J.-P., Gerdes, M., Al-Madhoun, A. S., Skerjanc, I. S., Figeys, D., Baetz, K.
(2008). Functional Dissection of the NuA4 Histone Acetyltransferase Reveals Its Role as a Genetic Hub and that Eaf1 Is Essential for Complex Integrity. Mol. Cell. Biol.
28: 2244-2256
[Abstract]
[Full Text]
-
Bermejo, C., Rodriguez, E., Garcia, R., Rodriguez-Pena, J. M., Rodriguez de la Concepcion, M. L., Rivas, C., Arias, P., Nombela, C., Posas, F., Arroyo, J.
(2008). The Sequential Activation of the Yeast HOG and SLT2 Pathways Is Required for Cell Survival to Cell Wall Stress. Mol. Biol. Cell
19: 1113-1124
[Abstract]
[Full Text]
-
Truman, A. W., Millson, S. H., Nuttall, J. M., Mollapour, M., Prodromou, C., Piper, P. W.
(2007). In the Yeast Heat Shock Response, Hsf1-Directed Induction of Hsp90 Facilitates the Activation of the Slt2 (Mpk1) Mitogen-Activated Protein Kinase Required for Cell Integrity. Eukaryot Cell
6: 744-752
[Abstract]
[Full Text]
-
Lesage, G., Bussey, H.
(2006). Cell Wall Assembly in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev.
70: 317-343
[Abstract]
[Full Text]
-
Jiang, Y.
(2006). Regulation of the Cell Cycle by Protein Phosphatase 2A in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev.
70: 440-449
[Abstract]
[Full Text]
-
Friesen, H., Humphries, C., Ho, Y., Schub, O., Colwill, K., Andrews, B.
(2006). Characterization of the Yeast Amphiphysins Rvs161p and Rvs167p Reveals Roles for the Rvs Heterodimer In Vivo. Mol. Biol. Cell
17: 1306-1321
[Abstract]
[Full Text]
-
Queralt, E., Igual, J. C.
(2005). Functional Connection Between the Clb5 Cyclin, the Protein Kinase C Pathway and the Swi4 Transcription Factor in Saccharomyces cerevisiae. Genetics
171: 1485-1498
[Abstract]
[Full Text]
-
Milgrom, E., West, R. W. Jr., Gao, C., Shen, W.-C. W.
(2005). TFIID and Spt-Ada-Gcn5-Acetyltransferase Functions Probed by Genome-wide Synthetic Genetic Array Analysis Using a Saccharomyces cerevisiae taf9-ts Allele. Genetics
171: 959-973
[Abstract]
[Full Text]
-
Kurischko, C., Weiss, G., Ottey, M., Luca, F. C.
(2005). A Role for the Saccharomyces cerevisiae Regulation of Ace2 and Polarized Morphogenesis Signaling Network in Cell Integrity. Genetics
171: 443-455
[Abstract]
[Full Text]
-
Mizunuma, M., Hirata, D., Miyakawa, T.
(2005). Implication of Pkc1p protein kinase C in sustaining Cln2p level and polarized bud growth in response to calcium signaling in Saccharomyces cerevisiae. J. Cell Sci.
118: 4219-4229
[Abstract]
[Full Text]
-
Rodriguez-Pena, J. M., Perez-Diaz, R. M., Alvarez, S., Bermejo, C., Garcia, R., Santiago, C., Nombela, C., Arroyo, J.
(2005). The 'yeast cell wall chip' - a tool to analyse the regulation of cell wall biogenesis in Saccharomyces cerevisiae. Microbiology
151: 2241-2249
[Abstract]
[Full Text]
-
Levin, D. E.
(2005). Cell Wall Integrity Signaling in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev.
69: 262-291
[Abstract]
[Full Text]
-
Imazu, H., Sakurai, H.
(2005). Saccharomyces cerevisiae Heat Shock Transcription Factor Regulates Cell Wall Remodeling in Response to Heat Shock. Eukaryot Cell
4: 1050-1056
[Abstract]
[Full Text]
-
Denis, V., Cyert, M. S.
(2005). Molecular Analysis Reveals Localization of Saccharomyces cerevisiae Protein Kinase C to Sites of Polarized Growth and Pkc1p Targeting to the Nucleus and Mitotic Spindle. Eukaryot Cell
4: 36-45
[Abstract]
[Full Text]
-
Garcia, R., Bermejo, C., Grau, C., Perez, R., Rodriguez-Pena, J. M., Francois, J., Nombela, C., Arroyo, J.
(2004). The Global Transcriptional Response to Transient Cell Wall Damage in Saccharomyces cerevisiae and Its Regulation by the Cell Integrity Signaling Pathway. J. Biol. Chem.
279: 15183-15195
[Abstract]
[Full Text]
-
Baetz, K. K., Krogan, N. J., Emili, A., Greenblatt, J., Hieter, P.
(2004). The ctf13-30/CTF13 Genomic Haploinsufficiency Modifier Screen Identifies the Yeast Chromatin Remodeling Complex RSC, Which Is Required for the Establishment of Sister Chromatid Cohesion. Mol. Cell. Biol.
24: 1232-1244
[Abstract]
[Full Text]
-
Reinoso-Martin, C., Schuller, C., Schuetzer-Muehlbauer, M., Kuchler, K.
(2003). The Yeast Protein Kinase C Cell Integrity Pathway Mediates Tolerance to the Antifungal Drug Caspofungin through Activation of Slt2p Mitogen-Activated Protein Kinase Signaling. Eukaryot Cell
2: 1200-1210
[Abstract]
[Full Text]
-
Green, R., Lesage, G., Sdicu, A.-M., Menard, P., Bussey, H.
(2003). A synthetic analysis of the Saccharomyces cerevisiae stress sensor Mid2p, and identification of a Mid2p-interacting protein, Zeo1p, that modulates the PKC1-MPK1 cell integrity pathway. Microbiology
149: 2487-2499
[Abstract]
[Full Text]
-
Costanzo, M., Schub, O., Andrews, B.
(2003). G1 Transcription Factors Are Differentially Regulated in Saccharomyces cerevisiae by the Swi6-Binding Protein Stb1. Mol. Cell. Biol.
23: 5064-5077
[Abstract]
[Full Text]
-
Lagorce, A., Hauser, N. C., Labourdette, D., Rodriguez, C., Martin-Yken, H., Arroyo, J., Hoheisel, J. D., Francois, J.
(2003). Genome-wide Analysis of the Response to Cell Wall Mutations in the Yeast Saccharomyces cerevisiae. J. Biol. Chem.
278: 20345-20357
[Abstract]
[Full Text]
-
Huang, D., Moffat, J., Andrews, B.
(2002). Dissection of a Complex Phenotype by Functional Genomics Reveals Roles for the Yeast Cyclin-Dependent Protein Kinase Pho85 in Stress Adaptation and Cell Integrity. Mol. Cell. Biol.
22: 5076-5088
[Abstract]
[Full Text]